These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 37894344)

  • 21. Molecular Repolarisation of Tumour-Associated Macrophages.
    van Dalen FJ; van Stevendaal MHME; Fennemann FL; Verdoes M; Ilina O
    Molecules; 2018 Dec; 24(1):. PubMed ID: 30577495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nanomaterials-Involved Tumor-Associated Macrophages' Reprogramming for Antitumor Therapy.
    Li SL; Hou HY; Chu X; Zhu YY; Zhang YJ; Duan MD; Liu J; Liu Y
    ACS Nano; 2024 Mar; 18(11):7769-7795. PubMed ID: 38420949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IRE1α inhibition by natural compound genipin on tumour associated macrophages reduces growth of hepatocellular carcinoma.
    Tan HY; Wang N; Tsao SW; Che CM; Yuen MF; Feng Y
    Oncotarget; 2016 Jul; 7(28):43792-43804. PubMed ID: 27270308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Macrophage metabolism, phenotype, function, and therapy in hepatocellular carcinoma (HCC).
    Huang J; Wu Q; Geller DA; Yan Y
    J Transl Med; 2023 Nov; 21(1):815. PubMed ID: 37968714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repolarization of macrophages to improve sorafenib sensitivity for combination cancer therapy.
    Huang L; Xu R; Li W; Lv L; Lin C; Yang X; Yao Y; Saw PE; Xu X
    Acta Biomater; 2023 May; 162():98-109. PubMed ID: 36931417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The significance of lipid metabolism reprogramming of tumor-associated macrophages in hepatocellular carcinoma.
    Xie Q; Zeng Y; Zhang X; Yu F
    Cancer Immunol Immunother; 2024 Jul; 73(9):171. PubMed ID: 38954021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting macrophages: a novel treatment strategy in solid tumors.
    Liu M; Liu L; Song Y; Li W; Xu L
    J Transl Med; 2022 Dec; 20(1):586. PubMed ID: 36510315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcription factor Zhx2 is a checkpoint that programs macrophage polarization and antitumor response.
    Tan S; Wang Z; Li N; Guo X; Zhang Y; Ma H; Peng X; Zhao Y; Li C; Gao L; Li T; Liang X; Ma C
    Cell Death Differ; 2023 Sep; 30(9):2104-2119. PubMed ID: 37582865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SIRT4 silencing in tumor-associated macrophages promotes HCC development via PPARδ signalling-mediated alternative activation of macrophages.
    Li Z; Li H; Zhao ZB; Zhu W; Feng PP; Zhu XW; Gong JP
    J Exp Clin Cancer Res; 2019 Nov; 38(1):469. PubMed ID: 31744516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autophagy-induced RelB/p52 activation mediates tumour-associated macrophage repolarisation and suppression of hepatocellular carcinoma by natural compound baicalin.
    Tan HY; Wang N; Man K; Tsao SW; Che CM; Feng Y
    Cell Death Dis; 2015 Oct; 6(10):e1942. PubMed ID: 26492375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor Associated Macrophages, as the Dominant Immune Cells, Are an Indispensable Target for Immunologically Cold Tumor-Glioma Therapy?
    Tong N; He Z; Ma Y; Wang Z; Huang Z; Cao H; Xu L; Zou Y; Wang W; Yi C; Yin Z; Wang Q
    Front Cell Dev Biol; 2021; 9():706286. PubMed ID: 34368156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Shaping Polarization Of Tumor-Associated Macrophages In Cancer Immunotherapy.
    Gao J; Liang Y; Wang L
    Front Immunol; 2022; 13():888713. PubMed ID: 35844605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma.
    Li X; Yao W; Yuan Y; Chen P; Li B; Li J; Chu R; Song H; Xie D; Jiang X; Wang H
    Gut; 2017 Jan; 66(1):157-167. PubMed ID: 26452628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting lipid metabolism of macrophages: A new strategy for tumor therapy.
    Shao N; Qiu H; Liu J; Xiao D; Zhao J; Chen C; Wan J; Guo M; Liang G; Zhao X; Xu L
    J Adv Res; 2024 Feb; ():. PubMed ID: 38373649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic regulation of tumor-associated macrophage heterogeneity: insights into the tumor microenvironment and immunotherapeutic opportunities.
    Qian Y; Yin Y; Zheng X; Liu Z; Wang X
    Biomark Res; 2024 Jan; 12(1):1. PubMed ID: 38185636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of tumor-associated macrophage in breast cancer biology.
    Choi J; Gyamfi J; Jang H; Koo JS
    Histol Histopathol; 2018 Feb; 33(2):133-145. PubMed ID: 28681373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preclinical and Clinical Therapeutic Strategies Affecting Tumor-Associated Macrophages in Hepatocellular Carcinoma.
    Degroote H; Van Dierendonck A; Geerts A; Van Vlierberghe H; Devisscher L
    J Immunol Res; 2018; 2018():7819520. PubMed ID: 30410942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crosstalk between tumor-associated macrophages and neighboring cells in hepatocellular carcinoma.
    Sung PS
    Clin Mol Hepatol; 2022 Jul; 28(3):333-350. PubMed ID: 34665953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolism in tumour-associated macrophages: a
    Zheng X; Mansouri S; Krager A; Grimminger F; Seeger W; Pullamsetti SS; Wheelock CE; Savai R
    Eur Respir Rev; 2020 Sep; 29(157):. PubMed ID: 33004525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Supramolecular Polymer-Nanomedicine Hydrogel Loaded with Tumor Associated Macrophage-Reprogramming polyTLR7/8a Nanoregulator for Enhanced Anti-Angiogenesis Therapy of Orthotopic Hepatocellular Carcinoma.
    Liu X; Huangfu Y; Wang J; Kong P; Tian W; Liu P; Fang C; Li S; Nie Y; Feng Z; Huang P; Shi S; Zhang C; Dong A; Wang W
    Adv Sci (Weinh); 2023 Aug; 10(22):e2300637. PubMed ID: 37229748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.